Inogen, Inc (INGN): Price and Financial Metrics
GET POWR RATINGS... FREE!
INGN POWR Grades
- Sentiment is the dimension where INGN ranks best; there it ranks ahead of 94.74% of US stocks.
- INGN's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
- INGN's current lowest rank is in the Growth metric (where it is better than 14.71% of US stocks).
INGN Stock Summary
- Price to trailing twelve month operating cash flow for INGN is currently 36.28, higher than 87.14% of US stocks with positive operating cash flow.
- For INGN, its debt to operating expenses ratio is greater than that reported by just 14.32% of US equities we're observing.
- With a year-over-year growth in debt of 72.24%, Inogen Inc's debt growth rate surpasses 88.83% of about US stocks.
- Stocks that are quantitatively similar to INGN, based on their financial statements, market capitalization, and price volatility, are SMSI, PRTS, JAMF, IDN, and VRNT.
- Visit INGN's SEC page to see the company's official filings. To visit the company's web site, go to www.inogen.com.
INGN Price Target
For more insight on analysts targets of INGN, see our INGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $69.00 | Average Broker Recommendation | 2 (Hold) |
INGN Stock Price Chart Interactive Chart >
INGN Price/Volume Stats
| Current price | $64.47 | 52-week high | $69.00 |
| Prev. close | $62.45 | 52-week low | $26.57 |
| Day low | $62.61 | Volume | 104,500 |
| Day high | $64.68 | Avg. volume | 157,368 |
| 50-day MA | $62.45 | Dividend yield | N/A |
| 200-day MA | $45.44 | Market Cap | 1.44B |
Inogen, Inc (INGN) Company Bio
Inogen develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company was founded in 2001 and is based in Goleta, California.
Latest INGN News From Around the Web
Below are the latest news stories about Inogen Inc that investors may wish to consider to help them evaluate INGN as an investment opportunity.
CVS Health (CVS) Deploys Time-Delay Safes in Georgia PharmaciesCVS Health's (CVS) time-delay safes are anticipated to help reduce robbery incidents. |
Inogen Announces Appointment of Chief Medical OfficerInogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Dr. Stanislav Glezer as Inogen’s Executive Vice President and Chief Medical Officer, effective June 21, 2021. |
Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases DropIn academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally. |
Medtronic (MDT) Progresses in Neuromodulation on New FDA NodMedtronic's (MDT) SenSight claims to deliver patient-specific DBS therapy for the treatment of symptoms associated with Parkinson's, dystonia and essential tremor and medically refractory epilepsy. |
Here's Why You Should Retain CVS Health (CVS) in Your PortfolioInvestors are optimistic about CVS Health (CVS) on solid first-quarter performance and growth in digital health services. |
INGN Price Returns
| 1-mo | -2.04% |
| 3-mo | 24.89% |
| 6-mo | 55.91% |
| 1-year | 96.23% |
| 3-year | -65.08% |
| 5-year | 30.98% |
| YTD | 44.29% |
| 2020 | -34.61% |
| 2019 | -44.97% |
| 2018 | 4.27% |
| 2017 | 77.28% |
| 2016 | 67.55% |
Continue Researching INGN
Want to see what other sources are saying about Inogen Inc's financials and stock price? Try the links below:Inogen Inc (INGN) Stock Price | Nasdaq
Inogen Inc (INGN) Stock Quote, History and News - Yahoo Finance
Inogen Inc (INGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...